Tiprelestat (Proteo)

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug NameTiprelestat (Proteo)
Drug Alias NameElafin
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLeukocyte elastase inhibitorsPancreatic elastase inhibitorsLeukocyte proteinase 3 inhibitors
TargetsPancreatic elastaseLeukocyte elastaseLeukocyte proteinase 3
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesProteo BiotechSri International
China Registration ClassN/A

Develop Information

Active CompaniesStanford University
Inactive CompaniesSri International
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank